[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:non-arteritic-anterior-ischemic-optic-neuropathy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Non-arteritic anterior ischemic optic neuropathy",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07453888","Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)",[11],"Phase 3","RECRUITING","2026-08-26T02:17:15.156099Z","2026-07-05T03:45:20.251324Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07290244","Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)",[19],"Phase 1","2026-08-26T02:15:11.740957Z","2026-05-05T02:35:31.899219Z",[],[]]